Financial Times Merck splits business to separate oncology from non-cancer drugs
Reshuffle in preparation for 2028 US patent expiry of blockbuster cancer treatment Keytruda
Reshuffle in preparation for 2028 US patent expiry of blockbuster cancer treatment Keytruda